Serina King
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Prostate Cancer Treatment and Research 11
- Prostate Cancer Diagnosis and Treatment 4
- Oncology 9
- PARP inhibition in cancer therapy 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Michael A. Carducci (12 shared papers)Emmanuel S. Antonarakis (11 shared papers)Michelle A. Rudek (5 shared papers)Rana Sullivan (6 shared papers)Роберто Пили (5 shared papers)David C. Smith (2 shared papers)Sushant K. Kachhap (1 shared paper)Daniel C. Danila (2 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)British Journal of Cancer (1 paper)The Journal of Urology (1 paper)The Prostate (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Serina King
17 papers receiving 513 citations
Peers
Comparison fields: 5 of 73
- Geriatrics and Gerontology 40
- Biochemistry 33
- Cancer Research 77
- Molecular Biology 342
- Oncology 129
Countries citing papers authored by Serina King
This map shows the geographic impact of Serina King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serina King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serina King more than expected).
Fields of papers citing papers by Serina King
This network shows the impact of papers produced by Serina King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serina King. The network helps show where Serina King may publish in the future.
Co-authors
The 25 scholars most cited alongside Serina King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 135 | |
| 2 | 2008 | 104 | |
| 3 | 2015 | 102 | |
| 4 | 2017 | 75 | |
| 5 | 2013 | 59 | |
| 6 | 2019 | 15 | |
| 7 | 2020 | 7 | |
| 8 | 2015 | 7 | |
| 9 | 2023 | 6 | |
| 10 | 2011 | 4 | |
| 11 | 2023 | 4 | |
| 12 | 2013 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2010 | 1 | |
| 15 | 2012 | 1 | |
| 16 | 2006 | 1 | |
| 17 | 2018 | 1 | |
| 18 | 2014 | 0 |
About Serina King
Serina King is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Nutrition and Dietetics and Surgery, having authored 18 papers that have together received 527 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Histone Deacetylase Inhibitors Research (4 papers), PARP inhibition in cancer therapy (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Epigenetics and DNA Methylation (3 papers), Pomegranate: compositions and health benefits (3 papers), Cancer Treatment and Pharmacology (2 papers) and Tannin, Tannase and Anticancer Activities (2 papers). The work is most often cited by research in Geriatrics and Gerontology (40 citations), Biochemistry (33 citations), Cancer Research (77 citations), Molecular Biology (342 citations) and Oncology (129 citations). Serina King has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Michael A. Carducci, Emmanuel S. Antonarakis, Michelle A. Rudek, Rana Sullivan, Роберто Пили, David C. Smith, Sushant K. Kachhap, Daniel C. Danila, Dana E. Rathkopf and Elisabeth I. Heath. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, The Journal of Urology, The Prostate and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.